Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:30:29.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or revision in the data related to Medical and healthcare publications and documentation.
    Difference
    0.2%
    Check dated 2024-06-06T14:52:53.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying age range, primary diagnosis, and compliance requirements, whereas previously no information was provided.
    Difference
    14%
    Check dated 2024-05-22T21:20:58.000Z thumbnail image
  8. Check
    47 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T23:00:57.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.